COIH.Y Stock Overview
Engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Croda International Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£22.11 |
| 52 Week High | UK£33.52 |
| 52 Week Low | UK£21.95 |
| Beta | 0.78 |
| 11 Month Change | -10.88% |
| 3 Month Change | -16.50% |
| 1 Year Change | -23.49% |
| 33 Year Change | -66.56% |
| 5 Year Change | -33.00% |
| Change since IPO | 38.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| COIH.Y | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -4.0% | 0.8% | 0.3% |
| 1Y | -23.5% | 11.4% | 31.1% |
Return vs Industry: COIH.Y underperformed the US Chemicals industry which returned 9.8% over the past year.
Return vs Market: COIH.Y underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| COIH.Y volatility | |
|---|---|
| COIH.Y Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: COIH.Y has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: COIH.Y's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 5,852 | Steve Foots | www.croda.com |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.
Croda International Plc Fundamentals Summary
| COIH.Y fundamental statistics | |
|---|---|
| Market cap | US$6.09b |
| Earnings (TTM) | US$204.93m |
| Revenue (TTM) | US$2.05b |
29.7x
P/E Ratio3.0x
P/S RatioIs COIH.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COIH.Y income statement (TTM) | |
|---|---|
| Revenue | UK£1.63b |
| Cost of Revenue | UK£914.80m |
| Gross Profit | UK£714.70m |
| Other Expenses | UK£552.00m |
| Earnings | UK£162.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 43.86% |
| Net Profit Margin | 9.98% |
| Debt/Equity Ratio | 27.2% |
How did COIH.Y perform over the long term?
See historical performance and comparison